| Product Code: ETC7648167 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Clinical Oncology NGS Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Clinical Oncology NGS Market - Industry Life Cycle |
3.4 Israel Clinical Oncology NGS Market - Porter's Five Forces |
3.5 Israel Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Israel Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 Israel Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Israel Clinical Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Technological advancements in next-generation sequencing (NGS) for clinical oncology |
4.2.3 Growing adoption of personalized medicine in oncology treatments |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology and services |
4.3.2 Regulatory challenges and compliance requirements in Israel healthcare sector |
5 Israel Clinical Oncology NGS Market Trends |
6 Israel Clinical Oncology NGS Market, By Types |
6.1 Israel Clinical Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Israel Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Israel Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Israel Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Israel Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F |
6.2 Israel Clinical Oncology NGS Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Israel Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.2.3 Israel Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.4 Israel Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F |
6.3 Israel Clinical Oncology NGS Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F |
6.3.3 Israel Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.3.4 Israel Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F |
6.4 Israel Clinical Oncology NGS Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 Israel Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Israel Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F |
7 Israel Clinical Oncology NGS Market Import-Export Trade Statistics |
7.1 Israel Clinical Oncology NGS Market Export to Major Countries |
7.2 Israel Clinical Oncology NGS Market Imports from Major Countries |
8 Israel Clinical Oncology NGS Market Key Performance Indicators |
8.1 Number of clinical oncology NGS tests conducted annually |
8.2 Adoption rate of NGS-based oncology treatments in Israel |
8.3 Rate of integration of NGS technology in clinical oncology practices |
9 Israel Clinical Oncology NGS Market - Opportunity Assessment |
9.1 Israel Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Israel Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 Israel Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Israel Clinical Oncology NGS Market - Competitive Landscape |
10.1 Israel Clinical Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Israel Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here